Maybe. Not trying to be a wet blanket here but if toxicity is an...

Maybe. Not trying to be a wet blanket here but if toxicity is an issue, then it will continue to be no matter what it is used for. Compound won't change. I actually thought that the toxicity problem had been solved so its mention surprised me a bit.

I'd be a bit concerned that there has been no updates on the COVID-19 trials - and, taking into account that there will need to be some secrecy provisions given that the holy grail is being hunted by several hundred companies and the patent could be worth a fortune, we can't expect full disclosure but there should have been some calming words from BIT about the trial.

Also, and I think most posters will have experience of this, it is normal when the goose lays a golden egg, that there some leakages of the fact and that will push the SP up - that is evidently missing at the moment.

A danger is that if the trials are a complete failure then that announcement could put downward pressure on the SP.